Us News

According to Fiscal.ai data, analysts expect the company to post earnings of $2.66 per share on revenue $4.77 billion.

Last year, the U.S. Federal Aviation Administration put a 38-per-month production cap on 737 Max jets after a door plug blew out of a Max aircraft last year.

Ives ups price target to suggest roughly 12% upside and kept a ‘Outperform’ rating.

The apex cryptocurrency advanced over 4% to $111,210.66, at time of writing, while Ethereum rose 4.5% to $4,058 and XRP gained 5.2% to $2.47.

According to Fiscal.ai-compiled consensus estimates, IBM is expected to report adjusted earnings per share of $2.44 and revenue of $16.10 billion for the third quarter of the fiscal year 2025.

The layoffs would continue through the year end and impact workforce across theatrical, streaming, linear and all other divisions.

The Phase 3 ROSELLA trial showed relacorilant plus chemotherapy helped patients with platinum-resistant ovarian cancer live longer without disease worsening, including those who failed prior PARP inhibitor treatment.

The company intends to pay Larvotto shareholders A$1.40 per share to acquire the remaining stake, which it does not own.

Jensen Huang said the home-made Blackwell wafer fulfills President Trump’s reindustrialization vision — to bring back manufacturing to America, to create jobs.

The Phase 3 trial showed Enhertu achieved a 67.3% complete response rate, outperforming standard therapy by more than 11 percentage points in high-risk HER2-positive early breast cancer.

BofA analysts said that management will need strong communication on credit risk to restore confidence.

Aptera is drawing investor attention after its Nasdaq debut, with shares swinging sharply as traders await the company’s first detailed look at its solar-powered vehicle plans and upcoming production roadmap.

The data positions Trodelvy as a potential new standard of care for patients with metastatic triple-negative breast cancer who aren’t eligible for immunotherapy.

The warning comes even as India’s Russian crude imports show signs of tapering off.

Beijing will likely signal heavy state-led investment in cutting-edge technologies at a key meeting of the Chinese Communist Party’s Central Committee.

Earlier this month, South Korea’s President Lee Jae Myung said that the country will raise defense spending by 8.2% to 66.3 trillion won.

The company’s late-stage trial showed patients on ivonescimab plus chemotherapy lived 11 months longer before their cancer worsened compared with those on standard treatment, while maintaining a manageable safety profile.

According to transcripts of the latest earnings call of these companies provided by Koyfin, Apple accounted for 63% of Skyworks’ revenue and 41% of Qorvo’s.

Wedbush expects Tesla’s third quarter to mark a shift toward steady demand and stronger execution, driven by Model Y refreshes, China recovery, and early momentum in its AI and robotics roadmap.

Jana Partners is urging Cooper to improve capital use and returns, saying its contact-lens and women’s health units lack strategic fit and drag on performance.

If successful, the IPO would value the unit at nearly $10 billion

The companies said they plan to deploy test vehicles based on the Peugeot e-Traveller model in Luxembourg in the coming months.

The Q3 guidance issued in late July calls for third-quarter revenue of $11.53 billion, marking 17.3% growth, an operating margin of 31.4% and EPS of $6.87.

A StreetInsider report attributed the renewed interest from Datadog to leadership changes at GitLab and the company's recent strong quarterly performance.

The company raised its fiscal year 2030 Oracle Cloud Infrastructure (OCI) revenue outlook to $166 billion.

Retail users on Stocktwits have largely overlooked the cancellation of the government grant.

Wall Street boosted the stock’s price targets after the company’s late-stage trial for its essential tremor drug, ulixacaltamide, delivered strong efficacy and safety data.

Credit concerns have also emerged as another significant headwind following disclosures from a few banks on Thursday.

China’s market regulator said the automaker will recall more than 115,000 Tang and Yuan Pro vehicles produced between 2015 and 2022.

The FDA’s new National Priority Voucher pilot helps with faster drug reviews, cutting timelines from nearly a year to weeks.

A White House official has said Indian refiners are cutting Russian oil imports by half after discussions between Prime Minister Modi and U.S. President Trump.

Trump may potentially announce new measures to expand access to in-vitro fertilization, including guidance for employers to offer supplemental fertility insurance and steep discounts on key IVF drugs.

Third-quarter revenue fell 1% year-over-year (Y-o-Y) to $3.587 billion, aligning with the consensus estimate, despite a 1% increase in volume.

Novo Nordisk is also continuing discussions with the administration under the Most Favored Nation policy aimed at linking U.S. drug costs to global benchmarks.

The dispute erupted after the Dutch government seized control of Chinese-owned Nexperia over security concerns, triggering retaliation from Beijing and raising fears of another supply shock for the auto industry.

Zuckerberg’s latest moonshot could set a new template for Big Tech data-center funding as Meta races toward AGI dominance.

Future Fund’s Gary Black doubts CEO Elon Musk will clarify robotaxi readiness as investors await key financial metrics.

However, Russia has expressed confidence that its energy partnership with India would continue

Baird said the development of the firm’s Neutron rocket will help the company enter the "highly lucrative" medium-lift market as a direct competitor to SpaceX's Falcon 9.

The stock has risen 45% this week amid optimism surrounding its Tonopah Flats Lithium Project in Nevada.

The newfound optimism toward Microvast could be traced back to the ongoing wrangling between the U.S. and China over the latter’s curbs on the export of rare earths, which are used for making battery materials.

KLAR stock has fallen 5.6% since its listing in September, when it raised $1.37 billion in IPO proceeds.

Hsinchu, Taiwan-based TSMC reported earnings per ADR of $2.92, up from $1.94 in the year-ago quarter and higher than the previous quarter’s $2.47.

The apex cryptocurrency was down over 1.7% at $110,673.64 at the time of writing, as per CoinMarketCap data. Ethereum slipped over 3% to $3,999.10, and XRP dipped 3.7% to $2.41.

The company said its cancer drug SLS009 showed strong preclinical results in T-cell prolymphocytic leukemia, improving survival and reducing tumor burden both alone and in combination with venetoclax.

Bank of New York Mellon, Charles Schwab, KeyCorp., Commercial Metals, M&T Bank, Marsh McLennan, Travelers, U.S. Bancorp, CSX, and Interactive Brokers are due to release their quarterly results.